CQR Course Categories
Radiation Therapy CQR Courses
CQR credit values for a course may not be the same as the biennial credit values for that same course. This section lists the credit values for CQR; however, your transcript and certificate will reflect CE credit values. This will not cause any issues upon submission to the ARRT. The 30 credit cap for a membership to eRADIMAGING is based on be/triennial CE credit values. You are responsible for tracking credits earned toward CQR. You may renew whenever you need to earn more credits.
| COURSE TITLE | SUBCATEGORY | CQR CREDITS | |
|---|---|---|---|
| Back to Basics: Radiography of the Upper Extremities | Treatment Sites and Tumors | 0.50 | 12/1/2024 |
| Human Trafficking: Identification, Assessment, and Patient Management in the Healthcare Setting | Patient Interactions and Management | 1.25 | 12/1/2024 |
| Clinical Applications and Advancements in Breast Sonography: A Comprehensive Review | Patient and Medical Record Management | 1.00 | 11/1/2024 |
| Clinical Applications and Advancements in Breast Sonography: A Comprehensive Review | Treatment Sites and Tumors | 0.50 | 11/1/2024 |
| The Role of Nuclear Imaging in Gastrointestinal Disorders: GI Cancers | Patient and Medical Records Management | 1.50 | 9/1/2024 |
| The Role of Nuclear Imaging in Gastrointestinal Disorders: GI Cancers | Treatment Sites and Tumors | 0.75 | 9/1/2024 |
| Breast Cancer Screening: Resolving the Differences in Benefits and Harms | Patient and Medical Records Management | 3.00 | 8/1/2024 |
| The Radiology Technologist and Infection Control in the Age of COVID-19 | Patient Interactions | 2.25 | 5/1/2024 |
| The Radiographer: Patient Education and Communication | Patient Interactions | 1.00 | 4/1/2024 |
| Patient-Centered Breast Imaging and Specialized Treatment | Patient Interactions | 0.75 | 1/1/2024 |
| The Radiologic Technologist, Ethics, and Patient Advocacy: An Update | Patient Interactions | 1.00 | 10/1/2023 |
| The Radiologic Technologist, Ethics, and Patient Advocacy: An Update | Radiation Protection | 0.25 | 10/1/2023 |
| Ethical Issues in Breast Cancer Screening | Patient Interactions | 0.25 | 9/1/2023 |
| Imaging Findings and Patient Management in HIV-Associated Malignancies | Treatment Sites and Tumors | 1.00 | 9/1/2023 |
| PET and PET/CT in the Diagnosis and Management of Follicular Lymphoma | Patient and Medical Record Management | 0.50 | 4/1/2023 |
| PET and PET/CT in the Diagnosis and Management of Follicular Lymphoma | Treatment Sites and Tumors | 0.25 | 4/1/2023 |
| The Role of Digital Radiography, Computed Tomography, Ultrasound, and Magnetic Resonance Imaging in the Diagnosis of Intimate Partner Violence | Patient Interactions | 0.50 | 2/1/2023 |
| Breast Imaging in High-Risk Patients | Patient and Medical Record Management | 1.00 | 10/1/2022 |
| Brachytherapy and Breast Cancer: Best Practices in Imaging-Based Patient Selection, Treatment Planning, and Future Trends | Patient and Medical Record Management | 0.25 | 8/1/2022 |
| Brachytherapy and Breast Cancer: Best Practices in Imaging-Based Patient Selection, Treatment Planning, and Future Trends | Treatments | 0.50 | 8/1/2022 |
| Radiation Exposure and Cancer Risk | Radiation Protection | 1.00 | 8/1/2022 |
| Three-Dimensional Digital Breast Tomosynthesis: An Update | Patient and Medical Record Management | 0.50 | 7/1/2022 |
| Imaging Benign Breast Diseases: The Role of Sonography and Mammography | Patient and Medical Record Management | 0.50 | 4/1/2022 |
| Imaging Benign Breast Diseases: The Role of Sonography and Mammography | Treatment Sites and Tumors | 0.25 | 4/1/2022 |
| Alternative Use of X-rays in the Past (“X-ray Frenzy”) and How Far We've Come | Radiation Protection | 0.25 | 3/1/2022 |
| Surgeon General's Workshop on Improving Health Literacy | Patient Interactions and Management | 3.00 | 3/1/2025 |
| Intraoperative Radiotherapy for Breast Cancer: Clinical Benefits, Risks, and Long-Term Effects | Treatment Sites and Tumors | 1.00 | 7/1/2024 |
| The Role of Radiolabeled PET/CT in the Diagnosis and Characterization of Prostate Cancer | Patient and Medical Record Management | 0.50 | 3/1/2024 |
| The Role of Radiolabeled PET/CT in the Diagnosis and Characterization of Prostate Cancer | Treatment Sites and Tumors | 0.50 | 3/1/2024 |
| Imaging and Ethical Considerations for Geriatric Patients | Patient Interactions | 1.00 | 6/1/2023 |
| Informed Decision Making and Consent: Principles and Applications | Patient Interactions | 1.00 | 11/1/2022 |
| Managing a Multigenerational Team of Imaging Professionals to Enhance Patient Care | Patient Interactions | 1.25 | 10/1/2022 |
| Current Perspectives and Future Directions in PET and Treatment Planning for Breast Imaging | Treatment Sites and Tumors | 0.25 | 2/1/2022 |
| Current Perspectives and Future Directions in PET and Treatment Planning for Breast Imaging | Treatment Volume Localization | 0.25 | 2/1/2022 |
| Radioimmunotherapy: A Review of I-131 Tositumomab and Y-90 Ibritumomab Tiuxetan for the Treatment of NHL | Treatment Sites and Tumors | 0.50 | 2/4/2022 |
| Challenges of Diagnosing and Treating Male Breast Cancer: Radiation Oncology Case Studies | Patient and Medical Record Management | 0.25 | 1/2/2023 |
| Challenges of Diagnosing and Treating Male Breast Cancer: Radiation Oncology Case Studies | Treatment Sites and Tumors | 0.25 | 1/2/2023 |
| Challenges of Diagnosing and Treating Male Breast Cancer: Radiation Oncology Case Studies | Treatment Volume Localization | 0.25 | 1/2/2023 |
| Challenges of Diagnosing and Treating Male Breast Cancer: Radiation Oncology Case Studies | Treatments | 0.25 | 1/2/2023 |
| A Review of MRI of the Breast and MRI-Guided Stereotactic Biopsy | Patient and Medical Record Management | 0.25 | 5/8/2022 |
| Screening for Breast Cancer: A New Approach | Patient and Medical Record Management | 0.50 | 5/7/2022 |
| The Role of Image Fusion in Medical Dosimetry | Prescription and Dose Calculation | 1.00 | 5/7/2022 |
| The Role and Value of Nuclear Medicine in the Imaging of Sentinel Nodes and Breast Cancer | Patient and Medical Record Management | 0.50 | 5/7/2022 |
| The Role and Value of Nuclear Medicine in the Imaging of Sentinel Nodes and Breast Cancer | Treatment Sites and Tumors | 0.25 | 5/7/2022 |
| The Role and Value of Nuclear Medicine in the Imaging of Sentinel Nodes and Breast Cancer | Treatments | 0.25 | 5/7/2022 |
| Image-Guided Radiation Therapy for Breast Cancer | Treatments | 1.00 | 5/7/2022 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers | Patient and Medical Record Management | 0.25 | 11/2/2022 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers | Treatment Sites and Tumors | 0.50 | 11/2/2022 |
| The Role of PET and PET/CT in the Diagnosis, Treatment Planning, and Post-Treatment Follow-up of HPV in Oropharyngeal and Anal Cancers | Treatments | 0.25 | 11/2/2022 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain | Patient and Medical Record Management | 0.25 | 4/26/2022 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain | Treatment Sites and Tumors | 0.50 | 4/26/2022 |
| The Role of Neuroimaging in Diagnosis and Treatment of Adult Gliomas of the Brain | Treatments | 0.25 | 4/26/2022 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer | Patient and Medical Record Management | 0.50 | 11/6/2022 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer | Treatment Sites and Tumors | 0.25 | 11/6/2022 |
| The Role of Imaging in Diagnosing and Managing the Treatment of Inflammatory Breast Cancer | Treatments | 0.25 | 11/6/2022 |
| Partial Breast Irradiation: An Alternative to Conventional Whole-Breast Irradiation | Prescription and Dose Calculation | 0.25 | 6/6/2022 |
| Partial Breast Irradiation: An Alternative to Conventional Whole-Breast Irradiation | Treatment Sites and Tumors | 0.25 | 6/6/2022 |
| Partial Breast Irradiation: An Alternative to Conventional Whole-Breast Irradiation | Treatments | 0.50 | 6/6/2022 |
984.227.8560Newsletter
Enter your email address to receive our new course alerts.